Health Care & Life Sciences » Pharmaceuticals | KYORIN Holdings Inc.

KYORIN Holdings Inc. | Income Statement

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
111,400
113,121
119,483
115,373
110,640
113,620
Cost of Goods Sold (COGS) incl. D&A
43,047
46,598
47,360
50,847
49,079
56,224
Gross Income
68,353
66,523
72,123
64,526
61,561
57,396
SG&A Expense
50,746
51,786
52,487
54,113
52,753
48,436
EBIT
17,607
14,737
19,636
10,413
8,808
8,960
Unusual Expense
18
2,235
2,696
1,025
807
-
Non Operating Income/Expense
668
5,038
1,894
316
1,030
397
Interest Expense
11
6
17
29
24
64
Pretax Income
18,312
17,561
18,815
9,716
9,061
9,359
Income Tax
6,287
5,497
5,176
2,411
2,486
2,490
Consolidated Net Income
12,025
12,064
13,639
7,305
6,574
6,869
Net Income
12,025
12,064
13,639
7,305
6,574
6,869
Net Income After Extraordinaries
12,025
12,064
13,639
7,305
6,574
6,869
Net Income Available to Common
12,025
12,064
13,639
7,305
6,574
6,869
EPS (Basic)
160.95
161.63
184.27
99.44
89.26
104.68
Basic Shares Outstanding
75
75
74
73
74
66
EPS (Diluted)
160.94
161.63
184.27
99.44
89.26
104.68
Diluted Shares Outstanding
75
75
74
73
74
66
EBITDA
20,824
17,790
23,366
14,032
12,452
11,900
Non-Operating Interest Income
44
34
22
17
28
32
Equity in Affiliates (Pretax)
22
7
24
23
28
36

About KYORIN Holdings

View Profile
Address
Ochanomizu Sola City, 16/F
Tokyo Tokyo 101
Japan
Employees -
Website http://www.kyorin-gr.co.jp
Updated 07/08/2019
KYORIN Holdings, Inc. engages in the development, manufacture and sale of pharmaceutical products through its subsidiaries. It operates through the following segments: Pharmaceutical Business and Healthcare Business. The Pharmaceutical Business segment engages in the production and sales of prescription drugs, generic drugs, and over the counter drugs.